Dr Pierre Martin-Hirsch
Job title: Consultant Gynaecological Oncologist and Gynaecologist
Department: Obstetrics and Gynaecology
Telephone number: 01772 524442
Primary medical qualification: MBCHB
Other qualifications: BSc FROG MD
Year of registration: 1987
GMC number: 420391
Career history:
Specialist training in obstetrics and gynaecology, NW Deanery .
Wellbeing Research Fellow, St James's University Hospital, Leeds
RCOG Subspecialty Trainee/ Lecturer in Gynaecological Oncology, Manchester University / Christie / St Mary’s Hospital .
Consultant Gynaecological Oncologist and Gynaecologist for Lancashire Teaching Hospitals NHS Foundation Trust (2001-present),
Trust Lead for Gynaecological Oncology
Hon Professor Lancaster University , Hon SL UCLAN, Editor BJOG & Secretary of British Colposcopy Society, Executive Board of International Federation of Colposcopy , North West Coastal research network lead for Reproductive Health and Gynaecological Oncology
Specialist areas: Gynaecological oncology; colposcopy; vulval / vaginal precancer; oncology training
Specialist Interests: Minimal access surgery, Vulval disorders , colposcopy, ovarian cancer surgery, patient information
Research interests: Evidence Based Practice in Gynaecological oncology, Imaging, Surgery in ovarian Cancer, Follow-up care, Patient information, Translational research, outcomes after treatment of cervical pre-cancer. >100 published papers. Supervision of academic trainees, clinical research fellows undertaking MDs, PHD students.
Clinics: Gynaecological Oncology Clinic; Colposcopy Clinic; Vulva CLinic; Gynaecology Clinic
Improving Outcomes in Gynaecological Oncology;
H.C. Kitchener, P.L. Martin-Hirsch 1997 NHS Executive
Pilot Study of Photodynamic Therapy For VIN / CIN
P.L. Martin-Hirsch, HC. Kitchener 1997 Central Manchester R+D
Supra-regional Audit of Maternity Care for Pregnant Adolescents
M.W. Seif, P.L. Martin-Hirsch, M. Maresh 1998 North West R+D
R.C.T. evaluating strategies to improve compliance for colposcopyA. Tomlinson, P.L. Martin-Hirsch 1998
Central Manchester R+D
R.C.T evaluating a novel collection device for cervical cytology
P.L. Martin-Hirsch, H. Kitchener 2000 Ampersand International
Cochrane / Systematic Reviews in Cervical Screening
P.L. Martin-Hirsch., M. Arbyn 2005 Cochrane Collaboration
Characterisation of cervical cells employing photothermal micro-spectroscopy +
Characterisation of DNA adducts in endometrium 2005+2006
P.L. Martin-Hirsch, F. Martin .LTHT and Rosemere Cancer Charity
Synucleins as Biomarkers and Potential Targets for Intervention in Cancer Progression
Dr. O El-Agnaf, P.Martin-Hirsch, S Aswad, F Martin 2005
Terry Fox Fund for Cancer Research
Human Ovarian Cancer: Stem Cells & Drug Resistance 2006
Professor Hassan T Hassan, P.L. Martin-Hirsch
NHS Cochrane Collaboration Programme Grant Scheme
Diagnosis and treatment of gynaecological cancer: improving the evidence for the NHS 2007
Khalid Khan, Sudha Sundhar, Pierre Martin-Hirsch, Trcey Roberts, Peter Guest Clinical Effectiveness of PET-CT imaging in restaging cervical cancer: systematic review and economic modelling: HTA June 2010
Andrea Rockall, Jon Hill, Pierre Martin-Hirsch, Sundha Sudhar, Richard Edmunson and Colleagues Prospective study evaluating PET in diagnosing lymph node disease in uterine and cervical cancer: Preston / Barts / Cambridge / Birmingham CRUK funded Nov 2010
C. Williams, P. Martin-Hirsch, R. Naik, J. Morrison S. Kehoe Optimising care, diagnosis and treatment pathways to ensure cost effectiveness and best practice in gynaecological cancer: improving the evidence for the NHS: NIHR Cochrane Collaboration Programme Grant Scheme Jan 2011
K. Beaver, P. Martin-Hirsch A.Tomlinson, S Williamson, C. Sutton Comparing hospital and telephone follow-up for women treated for endometrial cancer (ENDOCAT: Endometrial Cancer telephone follow-up trial. RFPB April 2011
Towards disease diagnosis through spectrochemical imaging of tissue architecture.
Engineering and Physics Research Council April 2013 : Weightman and colleagues.
Liverpool / Lancaster Universities I am a clinical partner with Lancashire Teaching Hospitals as the healthcare partner
Development of multimedia patient information resources for all cancers; Rosemere Cancer Charity 2014
Back to the list
Member of staff is senior author for forward thinking report
A member of staff at Lancashire Teaching Hospitals NHS Foundation Trust has led on the publication of a report providing new evidence on the effectiveness of a cervical cancer vaccination.
Almost all cases of cervical cancer are caused by the human papilloma virus (HPV). New evidence published shows that the HPV vaccine protects against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26.
Through completion of randomised trials of more than 73,000 girls and young women across 26 trials worldwide, researchers report that the HPV vaccine provides excellent protection against the virus. Research also found solid evidence that the vaccine is safe. This survey monitored these individuals for eight years following vaccination.
Pierre Martin-Hirsch, Consultant Gynaecologist at Lancashire Teaching Hospitals was a senior author for this Cohrane report, which has already had a huge impact nationally. Pierre said: “This study adds to the growing evidence that the HPV vaccine is effective in protecting girls and young women against cervical cancer.”
“As the cancer centre for Lancashire and South Cumbria, as well as a leading research centre, it’s really important that we’re involved in such pioneering studies, trials and programmes. This will enable us to bring emerging treatment and approaches to patients now, as well as break new ground in healthcare that will benefit future generations.”